Welcome Guest
Sign In
Register
Home
API
Manufacturing
Clinical Trials
Analytical Testing
Cold Chain
Articles
Facility Tours
News
Events
Videos
Clinical Trials Documentary
A Solid Dosage Future Documentary
Whitepapers/App Notes
Issue Archives
Company Focus
Service Directory
Register
Sign In
Home
Product and Service Directory
Bioprocess Technology and Services
Biopharmaceutical Contract Manufacturing / Biomanufacturing Services
Biopharmaceutical Contract Manufacturing / Biomanufacturing Services
Biopharmaceutical Contract Manufacturing / Biomanufacturing Services
Bioprocess and Biologics Development Services
Biotechnology Process Engineering Services
Custom Peptide Synthesis Services
Large-Scale Protein Production Services
News
Scinai Finalizes Corporate Reorganization, Separates CDMO and R&D Operations
Thursday, April 09, 2026
Scinai Immunotherapeutics has completed a strategic corporate reorganization that establishes a dedicated contract development and manufacturing organization (CDMO) subsidiary and a leaner research and development operation.
read more
Altruist Biologics' Hangzhou Facility Secures First Commercial Manufacturing License
Thursday, April 09, 2026
Altruist Biologics, an Innovent Biologics subsidiary and contract development and manufacturing organization (CDMO), announced that its Hangzhou facility was granted the Drug Product Manufacturing License (C Certificate) from the Chinese National Medical Products Administration (NMPA).
read more
Ofichem Consolidates Brands Under Unified CDMO Identity
Thursday, April 09, 2026
Ofichem has unified its business divisions under a single brand identity, announcing that all operations will now trade under the Ofichem name. The move consolidates several long-standing brands — including Ofichem BV, Ofipharma, Ofimedicine, Labatorium Ofichem, Ofichem Uppsala, and Avivia — into ...
read more
Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution
Tuesday, April 07, 2026
Azenta announced the appointment of Trey Martin as President of its Multiomics business, effective April 6, 2026. In this role, Mr. Martin will lead the Multiomics organization and report to John Marotta, Azenta's President and Chief Executive Officer.
read more
How AI is Transforming Clinical Trials
Monday, April 06, 2026
AI is already reshaping the clinical trials industry and that transformation looks set to continue over the next five years. New technologies will enable the development of more personalized medicines, empower more responsive trial designs and improve informed decision making by unlocking new data ...
read more
More News
Featured Videos
A Solid Dosage Future
In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules, pills). These traditional forms remain the ...
Pharma Flash - Layoffs and Mergers & Acquisitions - Plus Long COVID Study ...
Check out the top pharma news of the week from our Editor-In-Chief, Mike Auerbach. Watch video: In this week’s Pharma Flash – Emergent cuts business operations and reduces headcount. PrecisionLife releases COVID study results and Lilly and Regeneron...
More Videos
Featured Products and Services
We're sorry, no matching articles were found. Please select different filter options and try your search again.
More Featured Products
Featured Articles
We're sorry, no matching articles were found. Please select different filter options and try your search again.
Subscriptions
Get started here for your complimentary print or digital subscription
Sign up Now »